A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
Paik PK, James LP, Riely GJ, Azzoli CG, Miller VA, Ng KK, Sima CS, Heelan RT, Kris MG, Moore E, Rizvi NA.
Paik PK, et al. Among authors: heelan rt.
Cancer Chemother Pharmacol. 2011 Nov;68(5):1331-7. doi: 10.1007/s00280-011-1621-0. Epub 2011 Apr 3.
Cancer Chemother Pharmacol. 2011.
PMID: 21461889
Free PMC article.
Clinical Trial.